Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.03
PBH's Cash to Debt is ranked lower than
100% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.66 vs. PBH: 0.03 )
Ranked among companies with meaningful Cash to Debt only.
PBH' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.03 Max: N/A
Current: 0.03
Equity to Asset 0.27
PBH's Equity to Asset is ranked lower than
76% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.40 vs. PBH: 0.27 )
Ranked among companies with meaningful Equity to Asset only.
PBH' s Equity to Asset Range Over the Past 10 Years
Min: 0.2  Med: 0.38 Max: 0.48
Current: 0.27
0.2
0.48
Interest Coverage 2.98
PBH's Interest Coverage is ranked lower than
81% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.25 vs. PBH: 2.98 )
Ranked among companies with meaningful Interest Coverage only.
PBH' s Interest Coverage Range Over the Past 10 Years
Min: 2.27  Med: 2.49 Max: 3.41
Current: 2.98
2.27
3.41
F-Score: 7
Z-Score: 1.78
M-Score: -2.59
WACC vs ROIC
9.21%
7.63%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating margin (%) 32.51
PBH's Operating margin (%) is ranked higher than
96% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.25 vs. PBH: 32.51 )
Ranked among companies with meaningful Operating margin (%) only.
PBH' s Operating margin (%) Range Over the Past 10 Years
Min: -55.89  Med: 28.14 Max: 31.57
Current: 32.51
-55.89
31.57
Net-margin (%) 13.92
PBH's Net-margin (%) is ranked higher than
91% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.50 vs. PBH: 13.92 )
Ranked among companies with meaningful Net-margin (%) only.
PBH' s Net-margin (%) Range Over the Past 10 Years
Min: -61.61  Med: 10.48 Max: 12.16
Current: 13.92
-61.61
12.16
ROE (%) 16.60
PBH's ROE (%) is ranked higher than
73% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.00 vs. PBH: 16.60 )
Ranked among companies with meaningful ROE (%) only.
PBH' s ROE (%) Range Over the Past 10 Years
Min: -48.3  Med: 9.10 Max: 14.88
Current: 16.6
-48.3
14.88
ROA (%) 4.14
PBH's ROA (%) is ranked higher than
62% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.50 vs. PBH: 4.14 )
Ranked among companies with meaningful ROA (%) only.
PBH' s ROA (%) Range Over the Past 10 Years
Min: -20.19  Med: 3.32 Max: 4.11
Current: 4.14
-20.19
4.11
ROC (Joel Greenblatt) (%) 254.13
PBH's ROC (Joel Greenblatt) (%) is ranked higher than
98% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.89 vs. PBH: 254.13 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
PBH' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -396.15  Med: 212.77 Max: 299.62
Current: 254.13
-396.15
299.62
Revenue Growth (3Y)(%) 16.00
PBH's Revenue Growth (3Y)(%) is ranked higher than
86% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.60 vs. PBH: 16.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
PBH' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 14.35 Max: 84.2
Current: 16
0
84.2
EBITDA Growth (3Y)(%) 24.50
PBH's EBITDA Growth (3Y)(%) is ranked higher than
86% of the 35 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.30 vs. PBH: 24.50 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
PBH' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 25.85 Max: 59.3
Current: 24.5
0
59.3
EPS Growth (3Y)(%) 26.60
PBH's EPS Growth (3Y)(%) is ranked higher than
76% of the 33 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.50 vs. PBH: 26.60 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
PBH' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 25.80 Max: 263.6
Current: 26.6
0
263.6
» PBH's 10-Y Financials

Financials (Next Earnings Date: 2016-05-12)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2015

PBH Guru Trades in Q2 2015

Jim Simons 17,300 sh (New)
Joel Greenblatt 269,476 sh (+257.65%)
Paul Tudor Jones 22,447 sh (+9.82%)
Wallace Weitz 160,000 sh (unchged)
Ken Fisher 1,382,350 sh (-0.42%)
Murray Stahl 91,666 sh (-2.89%)
» More
Q3 2015

PBH Guru Trades in Q3 2015

Jim Simons 156,400 sh (+804.05%)
Wallace Weitz Sold Out
Ken Fisher 1,377,407 sh (-0.36%)
Paul Tudor Jones 15,473 sh (-31.07%)
Joel Greenblatt 119,178 sh (-55.77%)
Murray Stahl 36,716 sh (-59.95%)
» More
Q4 2015

PBH Guru Trades in Q4 2015

Jim Simons 396,100 sh (+153.26%)
Paul Tudor Jones 15,655 sh (+1.18%)
Ken Fisher 1,358,980 sh (-1.34%)
Murray Stahl 34,357 sh (-6.42%)
Joel Greenblatt 42,273 sh (-64.53%)
» More
Q1 2016

PBH Guru Trades in Q1 2016

Ken Fisher 1,469,457 sh (+8.13%)
Murray Stahl 20,357 sh (-40.75%)
» More
» Details

Insider Trades

Latest Guru Trades with PBH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 27.74
PBH's P/E(ttm) is ranked lower than
63% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.00 vs. PBH: 27.74 )
Ranked among companies with meaningful P/E(ttm) only.
PBH' s P/E(ttm) Range Over the Past 10 Years
Min: 7.85  Med: 20.05 Max: 492.31
Current: 27.74
7.85
492.31
PE(NRI) 27.74
PBH's PE(NRI) is ranked lower than
65% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.00 vs. PBH: 27.74 )
Ranked among companies with meaningful PE(NRI) only.
PBH' s PE(NRI) Range Over the Past 10 Years
Min: 7.93  Med: 19.89 Max: 426.67
Current: 27.74
7.93
426.67
Price/Owner Earnings (ttm) 74.28
PBH's Price/Owner Earnings (ttm) is ranked lower than
84% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 23.85 vs. PBH: 74.28 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
PBH' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 5.08  Med: 9.79 Max: 262.13
Current: 74.28
5.08
262.13
P/B 4.19
PBH's P/B is ranked lower than
77% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.19 vs. PBH: 4.19 )
Ranked among companies with meaningful P/B only.
PBH' s P/B Range Over the Past 10 Years
Min: 0.54  Med: 1.54 Max: 4.22
Current: 4.19
0.54
4.22
P/S 3.82
PBH's P/S is ranked lower than
86% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.10 vs. PBH: 3.82 )
Ranked among companies with meaningful P/S only.
PBH' s P/S Range Over the Past 10 Years
Min: 0.67  Med: 1.77 Max: 3.88
Current: 3.82
0.67
3.88
PFCF 16.56
PBH's PFCF is ranked higher than
63% of the 19 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.63 vs. PBH: 16.56 )
Ranked among companies with meaningful PFCF only.
PBH' s PFCF Range Over the Past 10 Years
Min: 3.12  Med: 11.01 Max: 109.53
Current: 16.56
3.12
109.53
POCF 16.14
PBH's POCF is ranked higher than
56% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.16 vs. PBH: 16.14 )
Ranked among companies with meaningful POCF only.
PBH' s POCF Range Over the Past 10 Years
Min: 3.1  Med: 9.62 Max: 107.3
Current: 16.14
3.1
107.3
EV-to-EBIT 17.28
PBH's EV-to-EBIT is ranked lower than
53% of the 38 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.35 vs. PBH: 17.28 )
Ranked among companies with meaningful EV-to-EBIT only.
PBH' s EV-to-EBIT Range Over the Past 10 Years
Min: -4.3  Med: 12.45 Max: 22.6
Current: 17.28
-4.3
22.6
EV-to-EBITDA 15.89
PBH's EV-to-EBITDA is ranked lower than
64% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.91 vs. PBH: 15.89 )
Ranked among companies with meaningful EV-to-EBITDA only.
PBH' s EV-to-EBITDA Range Over the Past 10 Years
Min: -4.6  Med: 11.20 Max: 20.8
Current: 15.89
-4.6
20.8
PEG 1.19
PBH's PEG is ranked higher than
71% of the 21 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.11 vs. PBH: 1.19 )
Ranked among companies with meaningful PEG only.
PBH' s PEG Range Over the Past 10 Years
Min: 0.95  Med: 1.15 Max: 1.33
Current: 1.19
0.95
1.33
Shiller P/E 102.75
PBH's Shiller P/E is ranked lower than
94% of the 17 Companies
in the Global Medical Distribution industry.

( Industry Median: 29.60 vs. PBH: 102.75 )
Ranked among companies with meaningful Shiller P/E only.
PBH' s Shiller P/E Range Over the Past 10 Years
Min: 83.36  Med: 99.31 Max: 206.71
Current: 102.75
83.36
206.71
Current Ratio 2.63
PBH's Current Ratio is ranked higher than
84% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.64 vs. PBH: 2.63 )
Ranked among companies with meaningful Current Ratio only.
PBH' s Current Ratio Range Over the Past 10 Years
Min: 1.7  Med: 2.20 Max: 3.98
Current: 2.63
1.7
3.98
Quick Ratio 1.70
PBH's Quick Ratio is ranked higher than
74% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.12 vs. PBH: 1.70 )
Ranked among companies with meaningful Quick Ratio only.
PBH' s Quick Ratio Range Over the Past 10 Years
Min: 1.08  Med: 1.38 Max: 3.05
Current: 1.7
1.08
3.05
Days Inventory 84.46
PBH's Days Inventory is ranked lower than
73% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 49.82 vs. PBH: 84.46 )
Ranked among companies with meaningful Days Inventory only.
PBH' s Days Inventory Range Over the Past 10 Years
Min: 69.11  Med: 75.29 Max: 87.68
Current: 84.46
69.11
87.68
Days Sales Outstanding 39.39
PBH's Days Sales Outstanding is ranked higher than
74% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 57.83 vs. PBH: 39.39 )
Ranked among companies with meaningful Days Sales Outstanding only.
PBH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 38.2  Med: 43.53 Max: 49.84
Current: 39.39
38.2
49.84
Days Payable 31.62
PBH's Days Payable is ranked lower than
85% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 62.84 vs. PBH: 31.62 )
Ranked among companies with meaningful Days Payable only.
PBH' s Days Payable Range Over the Past 10 Years
Min: 33.5  Med: 47.36 Max: 67.85
Current: 31.62
33.5
67.85

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 4.91
PBH's Price/Projected FCF is ranked lower than
81% of the 26 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.36 vs. PBH: 4.91 )
Ranked among companies with meaningful Price/Projected FCF only.
PBH' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.45  Med: 0.74 Max: 97.16
Current: 4.91
0.45
97.16
Price/Median PS Value 2.18
PBH's Price/Median PS Value is ranked lower than
89% of the 38 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.03 vs. PBH: 2.18 )
Ranked among companies with meaningful Price/Median PS Value only.
PBH' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.47  Med: 0.99 Max: 1.96
Current: 2.18
0.47
1.96
Price/Peter Lynch Fair Value 1.17
PBH's Price/Peter Lynch Fair Value is ranked higher than
73% of the 15 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.30 vs. PBH: 1.17 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
PBH' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.99  Med: 1.22 Max: 2.27
Current: 1.17
0.99
2.27
Earnings Yield (Greenblatt) (%) 5.80
PBH's Earnings Yield (Greenblatt) (%) is ranked higher than
53% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.70 vs. PBH: 5.80 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
PBH' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 4.4  Med: 7.70 Max: 13.7
Current: 5.8
4.4
13.7
Forward Rate of Return (Yacktman) (%) 23.47
PBH's Forward Rate of Return (Yacktman) (%) is ranked higher than
80% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.84 vs. PBH: 23.47 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
PBH' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 4.6  Med: 11.30 Max: 29.2
Current: 23.47
4.6
29.2

More Statistics

Revenue(Mil) $788
EPS $ 2.07
Beta1.26
Short Percentage of Float5.29%
52-Week Range $39.58 - 58.09
Shares Outstanding(Mil)52.75

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:NAS:PDCO, TSE:7459, SZSE:002589, NYSE:OMI, LSE:UDG » details
Traded in other countries:PBV.Germany,
Prestige Brands Holdings Inc is incorporated in the State of Delaware in 1996. The Company sells healthcare, household cleaning and personal care products in North America. It conducts its operations through two main business segments Over-the-Counter Healthcare and Household Cleaning. The Company's portfolio of Over-the-Counter (OTC) Healthcare products includes 14 core brands, including five from the GSK Brands acquisitions. Its core OTC brands are Chloraseptic sore throat remedies, Clear Eyes eye drops, Compound W wart removers, Little Remedies and PediaCare pediatric healthcare products, The Doctor's brand of oral care products, Efferdent and Effergrip denture products, Luden's drops, Dramamine motion sickness products, BC and Goody's analgesic powders, Beano gas prevention, Gaviscon antacids, and Debrox ear drops. Its other significant brands include Dermoplast first-aid products, Murine eye and ear care products, NasalCrom allergy prevention relief product, New-Skin liquid bandage, Wartner wart removers, Fiber Choice fiber laxative supplements, and Ecotrin aspirin. The Company's portfolio of household cleaning brands includes the Comet, Chore Boy and Spic and Span brands. Comet was originally introduced in 1956 and is recognized household cleaning brands. Chore Boy scrubbing pads and sponges were initially launched in the 1920's. Chore Boy products are currently sold in food and drugs stores, mass merchandisers, and in hardware and convenience stores. Competitors in the OTC Healthcare category include Johnson & Johnson; McNeil-PPC Tylenol(r) and Novartis Consumer Healthcare, each of which competes with its PediaCare and Little Remedies brands; The Procter & Gamble Company, maker of Vicks(r), and Reckitt Benckiser, maker of Cepacol(r), each of which competes with its Chloraseptic brand; Kraft Foods, maker of Halls(r), which competes with ourLuden's brand; The Procter & Gamble Company, maker of Fixodent(r), and GlaxoSmithKline, maker of Polident(r), each of which competes with its Efferdent brand; and Insight Pharmaceuticals, Inc., maker of Bonine(r), which competes with its Dramamine brand. Sunstar America, Inc., maker of the GUM(r) line of oral care products, as well as DenTek(r) Oral Care, Inc., which markets a dental protector for nighttime teeth grinding and interdental toothpicks, competes with its The Doctor's oral care brand. Competitors in the Household Cleaning category include: Henkel AG & Co., maker of Ajax(r) Cleanser, and The Clorox Company, maker of Tilex(r), each of which competes with its Comet brand. Additionally, Clorox's Pine Sol(r) and The Procter & Gamble Company's Mr. Clean(r) compete with its Spic and Span brand, while 3M Company, maker of Scotch-Brite(r),O-Cel-O(r) and Dobie(r) brands, and Clorox's SOS(r), compete with its Chore Boy brand. The Company is subject to a variety of other regulations in various foreign markets, including regulations pertaining to import/export regulations and antitrust iss
» More Articles for NYSE:PBH

Headlines

Articles On GuruFocus.com
Wallace Weitz Comments on Prestige Brands Holdings Nov 06 2015 
Earnings Upward Reaction: Prestige Brands Holdings (PBH), Proto Labs (PRLB) Feb 05 2015 
Meridian Funds Comments on Prestige Brands Sep 08 2014 
Meridian Growth Fund Second Quarter 2014 Commentary Sep 08 2014 
Paulson Bets Again On Mallinckrodt Aug 07 2014 
Private Capital Management Sells Update Nov 27 2013 
Gold Guru John Paulson Drops Gold ABX in First Quarter Sells May 18 2013 
Weekly CEO Sells Highlight: Smiths News, Prestige Brands Holdings, Proto Labs, Imax Corp Nov 26 2012 
Why I'd Never Pay More Than Book Value for Nokia (NOK) Apr 12 2012 
Prestige Brands Holdings Inc. Reports Operating Results (10-Q) Feb 09 2011 

More From Other Websites
Clear Eyes® Introduces Preservative-free Eye Drops, Clear Eyes® Pure Relief™ Apr 25 2016
Zacks Investment Ideas feature highlights: Aflac, Johnson & Johnson, LKQ, Prestige Brands and... Apr 22 2016
Nationwide Super Lice Infestation Meets its Match in a Brand New Over-the-Counter Remedy That Kills... Apr 21 2016
Prestige Brands Holdings, Inc. to Release Fiscal 2016 Fourth Quarter and Year End Earnings on May... Apr 11 2016
Prestige Brands Holdings, Inc. to Release Fiscal 2016 Fourth Quarter and Year End Earnings on May... Apr 11 2016
Prestige Brands (PBH) Stock Gets ‘Overweight’ Rating at Keybanc Mar 08 2016
Coverage initiated on Prestige Brands by KeyBanc Capital Mkts Mar 08 2016
Stocks Give Back Earlier Gains; FANG Stocks Drop, Crude Surges Mar 07 2016
Edited Transcript of PBH earnings conference call or presentation 5-Feb-15 1:30pm GMT Feb 29 2016
Discretionary Group May Hint At Outlook For 2016 Economy Feb 23 2016
PRESTIGE BRANDS HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Feb 19 2016
Prestige Brands Holdings, Inc. breached its 50 day moving average in a Bullish Manner : February 18,... Feb 18 2016
PRESTIGE BRANDS HOLDINGS, INC. Files SEC form 8-K, Regulation FD Disclosure Feb 16 2016
Prestige Brands Holdings, Inc. Announces Pricing of $350 Million Senior Notes Feb 16 2016
Prestige Brands, Inc. -- Moody's assigns Caa1 rating to Prestige Brands' notes offering; Outlook... Feb 16 2016
Prestige Brands Holdings, Inc. Announces Offering of $350 Million Senior Notes Feb 16 2016
Prestige Brands Holdings, Inc. Earnings Analysis: Q3, 2016 By the Numbers Feb 11 2016
PRESTIGE BRANDS HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Feb 09 2016
PRESTIGE BRANDS HOLDINGS, INC. Financials Feb 09 2016
Prestige Brands Holdings, Inc. Completes Acquisition of DenTek Holdings, Inc. Feb 08 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK